top of page
Search

Extracellular Communication




Mercury Bio has harnessed the power of extracellular communication via the creation of a yeast-derived, highly targeted drug delivery platform. This platform unleashes the potential for new medicines and vaccines to treat previously untreatable diseases and accelerate healing. 


See how the RDC 2021 & 2024 Technology & Manufacturing (TEAM) Fund awards helped Mercury Bio/Spartina Biotechnologies in its pre-patent preparation days during the COVID pandemic and its current expansion and commercialization phase.


For more information on our Technology & Manufacturing (TEAM) Fund: https://www.rdcnm.org/team-fund



Comments


bottom of page